PainReform (PainReform) Market Cap : $1.76 Mil (As of Jun. 01, 2024)

View and export this data going back to 2020. Start your Free Trial

What is PainReform Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PainReform's share price for the quarter that ended in Mar. 2024 was $1.82. PainReform's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 1.85 Mil. Therefore, PainReform's market cap for the quarter that ended in Mar. 2024 was $3.37 Mil.

PainReform's quarterly market cap declined from Sep. 2023 ($5.42 Mil) to Dec. 2023 ($4.75 Mil) and declined from Dec. 2023 ($4.75 Mil) to Mar. 2024 ($3.37 Mil).

PainReform's annual market cap declined from Dec. 2021 ($13.94 Mil) to Dec. 2022 ($4.39 Mil) but then increased from Dec. 2022 ($4.39 Mil) to Dec. 2023 ($4.75 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PainReform's Enterprise Value for Today is $-2.50 Mil.

PainReform Market Cap Historical Data

The historical data trend for PainReform's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PainReform Market Cap Chart

PainReform Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

39.15

13.94

4.39

4.75

PainReform Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial															7.40	5.99	5.42	4.75	3.37

Competitive Comparison of PainReform's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, PainReform's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PainReform's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PainReform's Market Cap distribution charts can be found below:

* The bar in red indicates where PainReform's Market Cap falls into.

PainReform Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

PainReform's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$2.75	*	1.72835
	=	$4.75

PainReform's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	$1.82	*	1.85024
	=	$3.37

PainReform (NAS:PRFX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

PainReform Market Cap Related Terms

Thank you for viewing the detailed overview of PainReform's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

PainReform (PainReform) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PainReform Ltd (NAS:PRFX) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Yigal Alon Street, Tel Aviv, ISR, 6744316

Website

https://www.painreform.com

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.